Cellecta Lands $1.8M SBIR Grant

The company will use the NCI funding to discover and validate gene targets involved in breast cancer that may affect a panel of epithelial cells involved in breast cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.